pyrazines has been researched along with isoquinoline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walker, MA | 1 |
| Avendaño, C; de la Cuesta, E; González, JF; Ortín, I | 1 |
| Bielawska, A; Bielawski, K; Czarnomysy, R; Gornowicz, A; Kałuża, Z; Lepiarczyk, M | 1 |
1 review(s) available for pyrazines and isoquinoline
| Article | Year |
|---|---|
Improvement in aqueous solubility achieved via small molecular changes.
Topics: Carbon; Drug Discovery; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Water | 2017 |
2 other study(ies) available for pyrazines and isoquinoline
| Article | Year |
|---|---|
Cytotoxicity of new pyrazino[1,2-b]isoquinoline and 6,15-iminoisoquino[3,2-b]3-benzazocine compounds.
Topics: Antineoplastic Agents; Azocines; Cell Line, Tumor; Humans; Isoquinolines; Pyrazines; Structure-Activity Relationship | 2010 |
Cytotoxic activity of octahydropyrazin[2,1-a:5,4-a']diisoquinoline derivatives in human breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Survival; Cytotoxins; Dose-Response Relationship, Drug; Female; Humans; Isoquinolines; MCF-7 Cells; Membrane Potential, Mitochondrial; Pyrazines | 2015 |